Experimental studies have shown that subfatin antagonises insulin resistance, and inhibits inflammation in adipose tissue through peroxisome proliferator-activated receptors gamma (PPARγ) and metabolism activation (7). This evidence concerns the gene PPARG and Insulin resistance.